5. References

  1. Clinical Pharmacology [database online]. Tampa, FL: Gold Standard, Inc.; 2022. Available at:  http://clinicalpharmacology-ip.com.ezproxy.lib.utexas.edu/. Accessed September 21, 2022.
  2. IMB Micromedex® DRUGDEX® (electronic version). Truven Health Analytics, Greenwood Village, Colorado, USA. Available at: http://www.micromedexsolutions.com.libproxy.uthscsa.edu. Accessed September 21, 2022.
  3. Amphetamine mixed salts tablets (Adderall®) package insert. Teva Pharmaceuticals USA, Inc., February 2022.
  4. Amphetamine mixed salts extended-release capsules (Adderall XR®) package insert.  Takeda Pharmaceuticals America, Inc., March 2022.
  5. Amphetamine mixed salts extended-release capsules (Mydayis®) package insert. Takeda Pharmaceuticals America, Inc., March 2022.
  6. Amphetamine extended-release orally disintegrating tablets (Adzenys XR-ODT®) package insert. Neos Therapeutics, Inc., March 2022.
  7. Amphetamine extended-release oral suspension (Dyanavel® XR) package insert. Nextwave Pharmaceuticals, Inc., May 2022.
  8. Dexmethylphenidate tablets (Focalin®) package insert. Novartis Pharmaceuticals Corp., June 2022.
  9. Dexmethylphenidate extended-release capsules (Focalin® XR) package insert. Novartis Pharmaceuticals Corp., June 2021.
  10. Dextroamphetamine transdermal system (Xelstrym®) package insert. Noven Therapeutics, LLC., March 2022.
  11. Lisdexamfetamine capsule and chewable tablets (Vyvanse®) package insert. Takeda Pharmaceuticals America, Inc., March 2022.
  12. Methylphenidate extended release capsules (Adhansia XR®) package insert. Adlon Therapeutics LP, July 2022.
  13. Methylphenidate extended-release capsules (Aptensio XR®) package insert.  Rhodes Pharmaceuticals, June 2021.
  14. Methylphenidate extended-release tablets (Concerta®) package insert. Janssen Pharmaceuticals, Inc., April 2022.
  15. Methylphenidate extended-release capsules (Jornay PM®) package insert. Ironshore Pharmaceuticals, Inc., March 2022.
  16. Methylphenidate extended-release capsules (Metadate CD®) package insert. Lannett Company, Inc., April 2022.
  17. Methylphenidate extended-release tablets package insert. KVK-Tech, Inc., April 2021.
  18. Methylphenidate oral solution (Methylin®) package insert. Shionogi Pharma, Inc., July 2021.
  19. Methylphenidate chewable tablets package insert. Camber Pharmaceuticals, Inc., August 2021. 
  20. Methylphenidate extended-release tablets (Relexxii®) package insert. Vertical Pharmaceuticals, LLC. November 2021.
  21. Methylphenidate tablets (Ritalin®) package insert. Novartis Pharmaceuticals Corp., June 2021.
  22. Methylphenidate extended-release capsules (Ritalin LA®) package insert.  Novartis Pharmaceuticals Corp., June 2021.
  23. Methylphenidate tablets, extended-release tablets package insert. Ascend Laboratories, LLC., December 2019. 
  24. Methylphenidate extended-release chewable tablets (QuilliChew® XR) package insert. NextWave Pharmaceuticals, Inc. June 2021.
  25. Methylphenidate extended-release oral suspension (Quillivant® XR) package insert. NextWave Pharmaceuticals, Inc. June 2021.
  26. Serdexmethylphenidate and dexmethylphenidate capsules (Azstarys®) package insert. Corium, Inc., May 2022.
  27. Atomoxetine (Strattera®) package insert. Eli Lilly and Company, January 2022.
  28. Viloxazine extended-release capsules (Qelbree®) package insert. Supernus Pharmaceuticals, Inc., May 2022.
  29. Guanfacine extended-release tablets (Intuniv®) package insert. Takeda Pharmaceuticals America Inc., January 2021.
  30. Texas Health and Human Services. Psychotropic medication utilization parameters for children and youth in Texas Public Behavioral Health (6th version). June 2019. Accessed September 22, 2022. Available at: https://www.hhs.texas.gov/sites/default/files/documents/doing-business-with-hhs/provider-portal/facilities-regulation/psychiatric/psychotropic-medication-utilization-parameters.pdf.
  31. Amphetamine sulfate tablets (Evekeo®) package insert. Arbor Pharmaceuticals. January 2022.
  32. Amphetamine sulfate oral disintegrating tablets (Evekeo ODT®) package insert. Arbor Pharmaceuticals. March 2022.
  33. Dextroamphetamine tablets package insert. Aurolife Pharma, LLC., January 2022.
  34. Dextroamphetamine extended-release capsules (Dexedrine® Spansule) package insert. Amneal Pharmaceuticals, LLC., January 2022.
  35. Dextroamphetamine oral solution (ProCentra®) package insert.  Independence Pharmaceuticals, June 2022.
  36. Dextroamphetamine tablets (Zenzedi®) package insert. Arbor Pharmaceuticals, LLC, January 2022.
  37. Methamphetamine tablets (Desoxyn®) package insert. Key Therapeutics, September 2022.
  38. Methylphenidate extended-release orally disintegrating tablets (Cotempla XR-ODT®) package insert. Neos Therapeutics, Inc., July 2021.
  39. Methylphenidate transdermal system (Daytrana®) package insert. Noven Pharmaceuticals, June 2021.
  40. Clonidine extended-release tablets (Kapvay®) package insert. Concordia Pharmaceuticals, Inc., August 2021.
  41. Diagnostic and Statistical Manual of Mental Disorders: DSM-5-TR. 5th ed., American Psychiatric Association, 2022.
  42. Wolraich ML, Hagan JF, Allan C, et. al. Subcommittee on Children and Adolescents with Attention-Deficit/Hyperactive Disorder; clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics. October 2019; 144 (4): e20192528. 10.1542/peds.2019-2528.